Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
22,183 | $3.283 | $72,827 | 159,724 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
19,348 | $3.283 | $63,519 | 106,194 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
23,790 | $3.283 | $78,103 | 1,481,003 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
11,333 | $3.283 | $37,206 | 86,244 (Direct) |
View |
| 2024-08-14 Sale |
2024-08-16 4:07 pm |
Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director |
8,846 | $3.6895 | $32,637 | 46,069 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:55 pm |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
4,358 | $2.3125 | $10,078 | 529,442 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:54 pm |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
9,593 | $2.3125 | $22,184 | 631,907 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:54 pm |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
9,982 | $2.3125 | $23,083 | 2,090,083 (Indirect Direct) |
View |
| 2024-02-02 Sale |
2024-02-05 7:54 pm |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
10,164 | $2.3125 | $23,504 | 1,999,893 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award(A) |
2025-04-01 5:47 pm |
N/A 2035-03-31 |
Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2025-03-31 Option Award |
2025-03-31 4:24 pm |
N/A 2035-03-31 |
Arbutus Biopharma Corp | ABUS | Nguyen Tuan Chief Financial Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2025-03-18 Option Award |
2025-03-20 4:14 pm |
N/A 2035-03-18 |
Arbutus Biopharma Corp | ABUS | Hasija Anuj Director |
157,600 | $0 | 157,600 (Direct) |
View |
| 2025-03-18 Option Award |
2025-03-20 4:10 pm |
N/A 2035-03-18 |
Arbutus Biopharma Corp | ABUS | Beardsley Robert A Director |
157,600 | $0 | 157,600 (Direct) |
View |
| 2025-03-18 Option Award |
2025-03-20 4:08 pm |
N/A 2035-03-18 |
Arbutus Biopharma Corp | ABUS | Androski Lindsay President and CEO |
310,422 | $0 | 310,422 (Direct) |
View |
Ownership |
2025-03-06 4:07 pm |
N/A N/A |
Arbutus Biopharma Corp | ABUS | Gline Matthew Director 10% Owner |
0 | $0 | 38,847,462 (Indirect) |
View |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
274,600 | $0 | 360,844 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
895,800 | $0 | 2,376,803 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
455,900 | $0 | 615,624 (Direct) |
View |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
249,600 | $0 | 355,794 (Direct) |
View |
| 2024-08-14 Exercise |
2024-08-16 4:07 pm |
N/A 2024-11-13 |
Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director |
54,915 | $0 | 46,069 (Direct) |
View |
| 2024-08-14 Exercise |
2024-08-16 4:07 pm |
N/A N/A |
Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director |
54,915 | $0.56 | 46,069 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:17 pm |
2024-05-23 2034-05-23 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:16 pm |
2024-05-23 2034-05-23 |
Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:14 pm |
2024-05-23 2034-05-23 |
Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:12 pm |
2024-05-23 2034-05-23 |
Arbutus Biopharma Corp | ABUS | Meyers James R Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:10 pm |
2024-05-23 2034-05-23 |
Arbutus Biopharma Corp | ABUS | Rewolinski Melissa Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-24 4:07 pm |
2024-05-23 2034-05-23 |
Arbutus Biopharma Corp | ABUS | Torti Frank Director |
67,000 | $0 | 67,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:55 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
475,600 | $0 | 475,600 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:55 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
504,900 | $0 | 529,442 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:54 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | HASTINGS DAVID C Chief Financial Officer |
562,500 | $0 | 631,907 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:54 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | Sofia Michael J. Chief Scientific Officer |
547,300 | $0 | 2,090,083 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:54 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | McElhaugh Michael J. Interim President & CEO |
618,900 | $0 | 1,999,893 (Direct) |
View |
| 2023-07-12 Option Award |
2023-07-13 4:13 pm |
N/A 2033-07-12 |
Arbutus Biopharma Corp | ABUS | Rewolinski Melissa Director |
110,000 | $0 | 110,000 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 4:50 pm |
N/A 2033-07-10 |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
153,640 | $0 | 153,640 (Direct) |
View |
Ownership |
2023-07-12 4:48 pm |
N/A N/A |
Arbutus Biopharma Corp | ABUS | Sims Karen Chief Medical Officer |
0 | $0 | 317,460 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 4:12 pm |
N/A 2033-07-10 |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-26 4:27 pm |
2023-05-24 2033-05-24 |
Arbutus Biopharma Corp | ABUS | HENRIQUES RICHARD C JR Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-26 4:22 pm |
2023-05-24 2033-05-24 |
Arbutus Biopharma Corp | ABUS | BURGESS DANIEL D Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-26 4:18 pm |
2023-05-24 2033-05-24 |
Arbutus Biopharma Corp | ABUS | MANCHESTER KEITH S Director |
55,000 | $0 | 55,000 (Direct) |
View |